Table 2. Summary Information of Genetic Instruments for Modifiable Risk Factors.
Risk factor | Unit | SNVs, No.a | LD thresholdb | Variation, % |
---|---|---|---|---|
Low-density lipoprotein cholesterol | SD in mmol/L | 220 | 0.001 | 7.7c |
Triglycerides | SD in mmol/L | 440 | 0.001 | 10.3c |
Apolipoprotein B | SD in g/L | 255 | 0.001 | 9.2c |
High-density lipoprotein cholesterol | SD in mmol/L | 534 | 0.001 | 11.9c |
Apolipoprotein A1 | SD in g/L | 440 | 0.001 | 10.1c |
Educational attainment | years | 3952 | 0.1 | 12-16 |
BMI | SD per 1 unit | 507 | 0.001 | 6 |
Smoking initiation | Ever smoked regularly vs never smoke | 378 | 0.1 | 2.3 |
Alcohol consumption | SD in alcoholic drinks per week | 99 | 0.1 | 0.7 |
Systolic blood pressure | 10 mm Hg | 266 | 0.1 | 5.7 |
Diastolic blood pressure | 10 mm Hg | 346 | 0.1 | 5.3 |
Type 2 diabetes | Log odds | 425 | 0.05 | 19 |
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); LD, linkage disequilibrium; SNV, single nucleotide variant.
Number of independent SNVs at genome-wide significance level (P < 5 × 10−8).
LD refers to the degree to which an allele of 1 genetic variant is inherited or correlated with an allele of a nearby genetic variant within a given population. The threshold to prune for LD was obtained in the original genome-wide association studies.
Variation explained by genetic instrumental variables were calculated based on the formula: β2 × 2 × MAF × (1 − MAF), where MAF denotes mean minor allele frequency from European populations, obtained through Phenoscanner V2. Calculation of the remaining percentages are given in the original articles.